Icahn School of Medicine at Mount Sinai
The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.
Inclusion Criteria: \- Patients age 16-24 years receiving POCT or lab-based GC/CT testing Exclusion Criteria: \- Patients with known HIV or active PrEP prescriptions.
Point-of-care testing for sexually transmitted infections.
Arctuva estimate
Verify or correct the compensation shown for this listing.